

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.77562856 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.46487673 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.35286518 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.07984207 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.99730499 |
| 6 | vocalization behavior (GO:0071625) | 5.76160420 |
| 7 | glutamate secretion (GO:0014047) | 5.55151775 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.41729307 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.37560424 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.26912058 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.24330209 |
| 12 | neuronal action potential propagation (GO:0019227) | 5.22303846 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.06255290 |
| 14 | exploration behavior (GO:0035640) | 4.99486044 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.90495693 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 4.86123567 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 4.83828836 |
| 18 | cerebellar granule cell differentiation (GO:0021707) | 4.83021586 |
| 19 | gamma-aminobutyric acid transport (GO:0015812) | 4.81553293 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 4.77092054 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.75416454 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 4.65895505 |
| 23 | positive regulation of synapse maturation (GO:0090129) | 4.63087831 |
| 24 | protein localization to synapse (GO:0035418) | 4.61450349 |
| 25 | sodium ion export (GO:0071436) | 4.56676667 |
| 26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.52643639 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.48700566 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.43545145 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 4.33145637 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.29947986 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.29271780 |
| 32 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.28314091 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.27194315 |
| 34 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.25667497 |
| 35 | response to pheromone (GO:0019236) | 4.06522937 |
| 36 | positive regulation of membrane potential (GO:0045838) | 4.03464929 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03435756 |
| 38 | * long-term memory (GO:0007616) | 4.00687668 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.98101150 |
| 40 | neuron cell-cell adhesion (GO:0007158) | 3.96046230 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.93499005 |
| 42 | proline transport (GO:0015824) | 3.92492019 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.91440358 |
| 44 | presynaptic membrane organization (GO:0097090) | 3.90226922 |
| 45 | neuromuscular process controlling balance (GO:0050885) | 3.88922906 |
| 46 | dendrite morphogenesis (GO:0048813) | 3.82163109 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.79120677 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.75747402 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74998959 |
| 50 | neurotransmitter transport (GO:0006836) | 3.71375839 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.68152989 |
| 52 | cell communication by electrical coupling (GO:0010644) | 3.65487025 |
| 53 | neuronal ion channel clustering (GO:0045161) | 3.65440749 |
| 54 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.61534309 |
| 55 | regulation of synaptic plasticity (GO:0048167) | 3.59971023 |
| 56 | synaptic vesicle endocytosis (GO:0048488) | 3.58881184 |
| 57 | amino acid import (GO:0043090) | 3.57645794 |
| 58 | cell migration in hindbrain (GO:0021535) | 3.57187869 |
| 59 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.56890421 |
| 60 | regulation of ARF protein signal transduction (GO:0032012) | 3.56735071 |
| 61 | cell differentiation in hindbrain (GO:0021533) | 3.56017145 |
| 62 | transmission of nerve impulse (GO:0019226) | 3.55890447 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.55888425 |
| 64 | potassium ion homeostasis (GO:0055075) | 3.54581916 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.52225302 |
| 66 | regulation of synapse maturation (GO:0090128) | 3.47588998 |
| 67 | regulation of neurotransmitter levels (GO:0001505) | 3.45472875 |
| 68 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.40111437 |
| 69 | neuromuscular process controlling posture (GO:0050884) | 3.39201424 |
| 70 | establishment of mitochondrion localization (GO:0051654) | 3.38446071 |
| 71 | membrane depolarization during action potential (GO:0086010) | 3.37613873 |
| 72 | establishment of nucleus localization (GO:0040023) | 3.35904708 |
| 73 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35513371 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.33458684 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.31654673 |
| 76 | membrane depolarization (GO:0051899) | 3.31557085 |
| 77 | auditory behavior (GO:0031223) | 3.31187658 |
| 78 | neuron recognition (GO:0008038) | 3.30427381 |
| 79 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.29894684 |
| 80 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.29538803 |
| 81 | long-term synaptic potentiation (GO:0060291) | 3.28331342 |
| 82 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28249649 |
| 83 | cellular sodium ion homeostasis (GO:0006883) | 3.25121641 |
| 84 | axonal fasciculation (GO:0007413) | 3.24457439 |
| 85 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.24184838 |
| 86 | neuromuscular synaptic transmission (GO:0007274) | 3.23421834 |
| 87 | glycine transport (GO:0015816) | 3.23189823 |
| 88 | dendritic spine organization (GO:0097061) | 3.22023947 |
| 89 | positive regulation of dendritic spine development (GO:0060999) | 3.22020147 |
| 90 | postsynaptic membrane organization (GO:0001941) | 3.21989742 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.21247286 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 3.20206145 |
| 93 | innervation (GO:0060384) | 3.20145864 |
| 94 | potassium ion import (GO:0010107) | 3.19684584 |
| 95 | L-amino acid import (GO:0043092) | 3.19352126 |
| 96 | long term synaptic depression (GO:0060292) | 3.14104253 |
| 97 | neuromuscular process (GO:0050905) | 3.12995153 |
| 98 | chemosensory behavior (GO:0007635) | 3.12376191 |
| 99 | startle response (GO:0001964) | 3.10254166 |
| 100 | cell communication involved in cardiac conduction (GO:0086065) | 3.09392849 |
| 101 | synapse assembly (GO:0007416) | 3.09075770 |
| 102 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08428862 |
| 103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.07659651 |
| 104 | adult walking behavior (GO:0007628) | 3.07274804 |
| 105 | membrane hyperpolarization (GO:0060081) | 3.05630448 |
| 106 | mechanosensory behavior (GO:0007638) | 3.04390893 |
| 107 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.03201221 |
| 108 | mitochondrion transport along microtubule (GO:0047497) | 3.03201221 |
| 109 | regulation of dendritic spine development (GO:0060998) | 3.02728734 |
| 110 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.02680023 |
| 111 | regulation of dendrite morphogenesis (GO:0048814) | 3.02526989 |
| 112 | positive regulation of dendrite development (GO:1900006) | 3.02061022 |
| 113 | response to auditory stimulus (GO:0010996) | 3.00414171 |
| 114 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.00370831 |
| 115 | learning (GO:0007612) | 3.00276264 |
| 116 | regulation of synaptic transmission (GO:0050804) | 2.99192139 |
| 117 | social behavior (GO:0035176) | 2.99058620 |
| 118 | intraspecies interaction between organisms (GO:0051703) | 2.99058620 |
| 119 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.98805975 |
| 120 | vesicle transport along microtubule (GO:0047496) | 2.96115378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.06941495 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15727753 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05520765 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.03360695 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99999246 |
| 6 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.85239595 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.81218681 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79026474 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79026474 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.60007754 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59108365 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57455156 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52970626 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50962782 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50329421 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44521349 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.42253110 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.35935296 |
| 19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33554720 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.32918185 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31208675 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.30327964 |
| 23 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20936666 |
| 24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20516616 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17621471 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.16721931 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82320705 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79138195 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.77536818 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74281053 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73268805 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66214136 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53981498 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51533374 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47167476 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41924144 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38911580 |
| 38 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38786178 |
| 39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38538919 |
| 40 | AR_19668381_ChIP-Seq_PC3_Human | 1.33620848 |
| 41 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33370348 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31098784 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29791444 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29334236 |
| 45 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28380466 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24117756 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22859192 |
| 48 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22825334 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21754217 |
| 50 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21210863 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21187032 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20300296 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19538446 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19091618 |
| 55 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18473992 |
| 56 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.17116142 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15936579 |
| 58 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.14426626 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14142782 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13792547 |
| 61 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.13668108 |
| 62 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13434006 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12962336 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11099436 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06614983 |
| 66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05784361 |
| 67 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05195091 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04605802 |
| 69 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04570947 |
| 70 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04415951 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04146382 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03339274 |
| 73 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03159791 |
| 74 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02169649 |
| 75 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01462485 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01321889 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99369402 |
| 78 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98071006 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97305514 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97213847 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96372094 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96170609 |
| 83 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95964684 |
| 84 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95854692 |
| 85 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95793935 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95410652 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94823111 |
| 88 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94572965 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94456425 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94443648 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93809625 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92017578 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90784590 |
| 94 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90636052 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90535663 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90325922 |
| 97 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89999066 |
| 98 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.89801724 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89051712 |
| 100 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88689854 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88658066 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88651396 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88231980 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87609158 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87609158 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87547280 |
| 107 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84967165 |
| 108 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84675238 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82838638 |
| 110 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81841337 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81724128 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81469696 |
| 113 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.81408586 |
| 114 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.78990613 |
| 115 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78771596 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77736822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004859_abnormal_synaptic_plasticity | 7.09384025 |
| 2 | * MP0003635_abnormal_synaptic_transmissio | 4.50523400 |
| 3 | MP0004270_analgesia | 4.06688246 |
| 4 | MP0003880_abnormal_central_pattern | 3.98788507 |
| 5 | MP0009046_muscle_twitch | 3.95836122 |
| 6 | MP0009745_abnormal_behavioral_response | 3.52024458 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.44116522 |
| 8 | MP0002064_seizures | 3.30677211 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.00483181 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.95559394 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.79522807 |
| 12 | MP0002272_abnormal_nervous_system | 2.79329993 |
| 13 | MP0008569_lethality_at_weaning | 2.75790944 |
| 14 | * MP0002734_abnormal_mechanical_nocicepti | 2.63873213 |
| 15 | MP0001486_abnormal_startle_reflex | 2.56777970 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.34884123 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.23717654 |
| 18 | MP0002736_abnormal_nociception_after | 2.22074600 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.20176637 |
| 20 | MP0003329_amyloid_beta_deposits | 2.13470774 |
| 21 | MP0002184_abnormal_innervation | 2.10891282 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.09122066 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.03303714 |
| 24 | MP0004858_abnormal_nervous_system | 1.89922116 |
| 25 | MP0000778_abnormal_nervous_system | 1.88695250 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.88652498 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.81807849 |
| 28 | MP0004885_abnormal_endolymph | 1.81559255 |
| 29 | * MP0001970_abnormal_pain_threshold | 1.81473641 |
| 30 | MP0004924_abnormal_behavior | 1.76265424 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.76265424 |
| 32 | * MP0002735_abnormal_chemical_nociception | 1.73669324 |
| 33 | MP0003879_abnormal_hair_cell | 1.73073170 |
| 34 | MP0000955_abnormal_spinal_cord | 1.71389947 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.70246023 |
| 36 | MP0003123_paternal_imprinting | 1.63123105 |
| 37 | MP0003122_maternal_imprinting | 1.62421616 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.61755283 |
| 39 | MP0002066_abnormal_motor_capabilities/c | 1.55031941 |
| 40 | MP0002822_catalepsy | 1.54364502 |
| 41 | MP0003633_abnormal_nervous_system | 1.50378167 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.48934916 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.39182119 |
| 44 | MP0003631_nervous_system_phenotype | 1.35700022 |
| 45 | MP0004142_abnormal_muscle_tone | 1.28227289 |
| 46 | MP0003632_abnormal_nervous_system | 1.24479815 |
| 47 | * MP0002152_abnormal_brain_morphology | 1.21201945 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.21001695 |
| 49 | MP0003787_abnormal_imprinting | 1.18205829 |
| 50 | MP0001984_abnormal_olfaction | 1.17411957 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.15655953 |
| 52 | MP0004742_abnormal_vestibular_system | 1.07184032 |
| 53 | MP0008872_abnormal_physiological_respon | 1.05216108 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.01787338 |
| 55 | MP0002229_neurodegeneration | 1.01073868 |
| 56 | MP0003690_abnormal_glial_cell | 1.00697871 |
| 57 | MP0004510_myositis | 1.00000797 |
| 58 | MP0000604_amyloidosis | 0.99285112 |
| 59 | MP0003283_abnormal_digestive_organ | 0.97508127 |
| 60 | MP0000920_abnormal_myelination | 0.94666607 |
| 61 | MP0001177_atelectasis | 0.94079849 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 0.91416177 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 0.91237193 |
| 64 | MP0002069_abnormal_eating/drinking_beha | 0.90597974 |
| 65 | MP0003075_altered_response_to | 0.88149498 |
| 66 | MP0004215_abnormal_myocardial_fiber | 0.87566148 |
| 67 | MP0003121_genomic_imprinting | 0.86440004 |
| 68 | MP0008874_decreased_physiological_sensi | 0.85979315 |
| 69 | MP0006276_abnormal_autonomic_nervous | 0.83710570 |
| 70 | MP0003634_abnormal_glial_cell | 0.83653471 |
| 71 | MP0000751_myopathy | 0.83515527 |
| 72 | MP0008877_abnormal_DNA_methylation | 0.82798727 |
| 73 | MP0005409_darkened_coat_color | 0.81475797 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.81464843 |
| 75 | MP0001529_abnormal_vocalization | 0.81301395 |
| 76 | MP0004484_altered_response_of | 0.80522953 |
| 77 | MP0001963_abnormal_hearing_physiology | 0.79195015 |
| 78 | MP0004085_abnormal_heartbeat | 0.78143505 |
| 79 | MP0005187_abnormal_penis_morphology | 0.77701508 |
| 80 | MP0003137_abnormal_impulse_conducting | 0.77446550 |
| 81 | MP0004233_abnormal_muscle_weight | 0.74383247 |
| 82 | MP0001905_abnormal_dopamine_level | 0.71579708 |
| 83 | MP0005535_abnormal_body_temperature | 0.70994749 |
| 84 | MP0001346_abnormal_lacrimal_gland | 0.70849568 |
| 85 | MP0004147_increased_porphyrin_level | 0.70819906 |
| 86 | MP0002752_abnormal_somatic_nervous | 0.70095934 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.69656069 |
| 88 | MP0004043_abnormal_pH_regulation | 0.69372349 |
| 89 | MP0002089_abnormal_postnatal_growth/wei | 0.69155056 |
| 90 | MP0002090_abnormal_vision | 0.68970199 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.68954206 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.67989918 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.67436220 |
| 94 | MP0005394_taste/olfaction_phenotype | 0.65280590 |
| 95 | MP0005499_abnormal_olfactory_system | 0.65280590 |
| 96 | MP0003861_abnormal_nervous_system | 0.65041505 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.64211333 |
| 98 | MP0010769_abnormal_survival | 0.63039787 |
| 99 | MP0001188_hyperpigmentation | 0.61909404 |
| 100 | MP0001485_abnormal_pinna_reflex | 0.61379796 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.60841843 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.60801352 |
| 103 | MP0010768_mortality/aging | 0.59196565 |
| 104 | MP0004130_abnormal_muscle_cell | 0.58704439 |
| 105 | MP0001943_abnormal_respiration | 0.58086449 |
| 106 | MP0002082_postnatal_lethality | 0.57740286 |
| 107 | MP0010770_preweaning_lethality | 0.57740286 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.57224546 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.57195475 |
| 110 | MP0003938_abnormal_ear_development | 0.55099674 |
| 111 | MP0000579_abnormal_nail_morphology | 0.54842656 |
| 112 | MP0003045_fibrosis | 0.54002054 |
| 113 | MP0010386_abnormal_urinary_bladder | 0.53606084 |
| 114 | MP0003956_abnormal_body_size | 0.53511841 |
| 115 | MP0002081_perinatal_lethality | 0.52615708 |
| 116 | MP0000026_abnormal_inner_ear | 0.50340425 |
| 117 | MP0005171_absent_coat_pigmentation | 0.49960668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.04432058 |
| 2 | Myokymia (HP:0002411) | 6.80503293 |
| 3 | Visual hallucinations (HP:0002367) | 5.85193569 |
| 4 | Action tremor (HP:0002345) | 5.69929557 |
| 5 | Focal seizures (HP:0007359) | 5.65624009 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 5.62013557 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.62264026 |
| 8 | Gaze-evoked nystagmus (HP:0000640) | 4.58510995 |
| 9 | Atonic seizures (HP:0010819) | 4.39891988 |
| 10 | Febrile seizures (HP:0002373) | 4.30997348 |
| 11 | Broad-based gait (HP:0002136) | 4.11655252 |
| 12 | Dysdiadochokinesis (HP:0002075) | 3.96796173 |
| 13 | Absence seizures (HP:0002121) | 3.95218915 |
| 14 | Impaired smooth pursuit (HP:0007772) | 3.80986570 |
| 15 | Poor eye contact (HP:0000817) | 3.77301604 |
| 16 | Abnormality of the lower motor neuron (HP:0002366) | 3.69088801 |
| 17 | Scanning speech (HP:0002168) | 3.66907495 |
| 18 | Genetic anticipation (HP:0003743) | 3.63621285 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.60418617 |
| 20 | Intention tremor (HP:0002080) | 3.58676379 |
| 21 | Dysmetria (HP:0001310) | 3.57982285 |
| 22 | Dysmetric saccades (HP:0000641) | 3.56986983 |
| 23 | Dialeptic seizures (HP:0011146) | 3.53327992 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.49577421 |
| 25 | Mutism (HP:0002300) | 3.43561107 |
| 26 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.42758783 |
| 27 | Hemiplegia (HP:0002301) | 3.39397731 |
| 28 | Impaired social interactions (HP:0000735) | 3.37813770 |
| 29 | Abnormal social behavior (HP:0012433) | 3.37813770 |
| 30 | Diplopia (HP:0000651) | 3.35492598 |
| 31 | Abnormality of binocular vision (HP:0011514) | 3.35492598 |
| 32 | Truncal ataxia (HP:0002078) | 3.35015482 |
| 33 | Depression (HP:0000716) | 3.19740081 |
| 34 | Ankle clonus (HP:0011448) | 3.17712477 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.15760774 |
| 36 | Hemiparesis (HP:0001269) | 3.09541853 |
| 37 | Papilledema (HP:0001085) | 3.08086878 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.89599801 |
| 39 | Postural instability (HP:0002172) | 2.88733430 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.87944934 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.82580099 |
| 42 | Annular pancreas (HP:0001734) | 2.76538073 |
| 43 | Anxiety (HP:0000739) | 2.76273044 |
| 44 | Hyperventilation (HP:0002883) | 2.72520916 |
| 45 | Abnormality of the corticospinal tract (HP:0002492) | 2.65581171 |
| 46 | Drooling (HP:0002307) | 2.64860057 |
| 47 | Excessive salivation (HP:0003781) | 2.64860057 |
| 48 | Stereotypic behavior (HP:0000733) | 2.64415729 |
| 49 | Ventricular fibrillation (HP:0001663) | 2.64193142 |
| 50 | Status epilepticus (HP:0002133) | 2.62990630 |
| 51 | Spastic gait (HP:0002064) | 2.57310823 |
| 52 | Cerebral hypomyelination (HP:0006808) | 2.52689877 |
| 53 | Amblyopia (HP:0000646) | 2.50737788 |
| 54 | Urinary urgency (HP:0000012) | 2.47877355 |
| 55 | Megalencephaly (HP:0001355) | 2.44381739 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.42428890 |
| 57 | Tetraplegia (HP:0002445) | 2.41713908 |
| 58 | Fetal akinesia sequence (HP:0001989) | 2.36261829 |
| 59 | Bundle branch block (HP:0011710) | 2.35355936 |
| 60 | Abnormality of saccadic eye movements (HP:0000570) | 2.34705158 |
| 61 | Sleep apnea (HP:0010535) | 2.33908032 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.33388433 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.32828725 |
| 64 | Agitation (HP:0000713) | 2.32797686 |
| 65 | Obstructive sleep apnea (HP:0002870) | 2.30891857 |
| 66 | Bradykinesia (HP:0002067) | 2.29382853 |
| 67 | Pointed chin (HP:0000307) | 2.29269682 |
| 68 | Torticollis (HP:0000473) | 2.27570327 |
| 69 | Impaired vibratory sensation (HP:0002495) | 2.26046671 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.25831152 |
| 71 | Gait ataxia (HP:0002066) | 2.23368121 |
| 72 | Lower limb asymmetry (HP:0100559) | 2.23300012 |
| 73 | Focal dystonia (HP:0004373) | 2.22562642 |
| 74 | Progressive inability to walk (HP:0002505) | 2.21535212 |
| 75 | Inappropriate behavior (HP:0000719) | 2.19307290 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.18791784 |
| 77 | Postural tremor (HP:0002174) | 2.16547330 |
| 78 | Absent speech (HP:0001344) | 2.15042645 |
| 79 | Horizontal nystagmus (HP:0000666) | 2.13007903 |
| 80 | Polyphagia (HP:0002591) | 2.10969638 |
| 81 | Limb ataxia (HP:0002070) | 2.07071563 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.06242900 |
| 83 | Diminished motivation (HP:0000745) | 2.04202295 |
| 84 | Termporal pattern (HP:0011008) | 2.03981319 |
| 85 | Insidious onset (HP:0003587) | 2.03981319 |
| 86 | Insomnia (HP:0100785) | 2.03019350 |
| 87 | Aqueductal stenosis (HP:0002410) | 2.02635317 |
| 88 | Clonus (HP:0002169) | 1.99943163 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.99513254 |
| 90 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99445623 |
| 91 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99445623 |
| 92 | Generalized myoclonic seizures (HP:0002123) | 1.98160915 |
| 93 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97582226 |
| 94 | Aplasia involving bones of the extremities (HP:0009825) | 1.97582226 |
| 95 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97582226 |
| 96 | Delusions (HP:0000746) | 1.91754876 |
| 97 | Lower limb amyotrophy (HP:0007210) | 1.91652576 |
| 98 | Apathy (HP:0000741) | 1.91461476 |
| 99 | Turricephaly (HP:0000262) | 1.90757419 |
| 100 | Incomplete penetrance (HP:0003829) | 1.90481769 |
| 101 | Lower limb muscle weakness (HP:0007340) | 1.89331869 |
| 102 | Pheochromocytoma (HP:0002666) | 1.89262608 |
| 103 | Spastic tetraparesis (HP:0001285) | 1.85746220 |
| 104 | Intellectual disability, profound (HP:0002187) | 1.85160453 |
| 105 | Peripheral hypomyelination (HP:0007182) | 1.84826491 |
| 106 | Craniofacial dystonia (HP:0012179) | 1.81172562 |
| 107 | Spinal canal stenosis (HP:0003416) | 1.75563733 |
| 108 | Bronchomalacia (HP:0002780) | 1.75077173 |
| 109 | Psychosis (HP:0000709) | 1.74873505 |
| 110 | Prolonged QT interval (HP:0001657) | 1.73869834 |
| 111 | Syncope (HP:0001279) | 1.72837219 |
| 112 | Inability to walk (HP:0002540) | 1.72668385 |
| 113 | Limb dystonia (HP:0002451) | 1.72460322 |
| 114 | Spastic tetraplegia (HP:0002510) | 1.72046083 |
| 115 | Rapidly progressive (HP:0003678) | 1.71281956 |
| 116 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70916955 |
| 117 | Rigidity (HP:0002063) | 1.70088809 |
| 118 | CNS hypomyelination (HP:0003429) | 1.69971785 |
| 119 | Akinesia (HP:0002304) | 1.68404636 |
| 120 | Abnormality of salivation (HP:0100755) | 1.68353337 |
| 121 | Abnormality of the periventricular white matter (HP:0002518) | 1.68337873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.22267793 |
| 2 | MAP3K9 | 4.08060082 |
| 3 | MARK1 | 4.07063718 |
| 4 | EPHA4 | 3.16875389 |
| 5 | MAP3K4 | 2.85719211 |
| 6 | MINK1 | 2.85396695 |
| 7 | DAPK2 | 2.80871802 |
| 8 | CAMKK1 | 2.51850327 |
| 9 | PAK6 | 2.44885868 |
| 10 | NTRK2 | 2.31584976 |
| 11 | MAP2K7 | 2.22251378 |
| 12 | CAMKK2 | 2.20189262 |
| 13 | PRKD3 | 2.04833192 |
| 14 | KSR2 | 1.94042689 |
| 15 | MAP2K4 | 1.85912161 |
| 16 | RIPK1 | 1.77559023 |
| 17 | STK38 | 1.75893557 |
| 18 | PRPF4B | 1.74000844 |
| 19 | NTRK1 | 1.61754437 |
| 20 | RIPK4 | 1.57462802 |
| 21 | CDK5 | 1.54618424 |
| 22 | CDK19 | 1.54122974 |
| 23 | KSR1 | 1.52427092 |
| 24 | DAPK1 | 1.49440702 |
| 25 | TNIK | 1.33042163 |
| 26 | SIK2 | 1.32820265 |
| 27 | MAPK13 | 1.32614315 |
| 28 | PRKCG | 1.32431352 |
| 29 | TYRO3 | 1.30007775 |
| 30 | PHKG1 | 1.27481381 |
| 31 | PHKG2 | 1.27481381 |
| 32 | CAMK1 | 1.15620163 |
| 33 | PLK2 | 1.15224180 |
| 34 | GRK5 | 1.13731897 |
| 35 | MAP3K2 | 1.12923427 |
| 36 | PNCK | 1.10053461 |
| 37 | STK11 | 1.08929939 |
| 38 | ALK | 1.05747691 |
| 39 | MAP3K12 | 1.05038446 |
| 40 | LATS2 | 0.99945946 |
| 41 | CDK15 | 0.99685770 |
| 42 | TAOK1 | 0.99366242 |
| 43 | CDK18 | 0.97806635 |
| 44 | WNK1 | 0.97539869 |
| 45 | PRKCH | 0.97093437 |
| 46 | UHMK1 | 0.93475568 |
| 47 | RET | 0.91830587 |
| 48 | SGK223 | 0.90746872 |
| 49 | SGK494 | 0.90746872 |
| 50 | CASK | 0.89520830 |
| 51 | CDK14 | 0.88230725 |
| 52 | CDK11A | 0.87162046 |
| 53 | CAMK2A | 0.83714848 |
| 54 | FES | 0.83415248 |
| 55 | MARK2 | 0.82977238 |
| 56 | SGK2 | 0.82433570 |
| 57 | SGK3 | 0.82294943 |
| 58 | PDK1 | 0.81239390 |
| 59 | MAP3K13 | 0.79696620 |
| 60 | DYRK1A | 0.79205117 |
| 61 | CAMK2B | 0.77571564 |
| 62 | FGFR2 | 0.76239455 |
| 63 | PINK1 | 0.75801043 |
| 64 | SCYL2 | 0.74717395 |
| 65 | OXSR1 | 0.73085068 |
| 66 | SGK1 | 0.72293843 |
| 67 | CAMK4 | 0.69597329 |
| 68 | DYRK2 | 0.69068070 |
| 69 | CSNK1G2 | 0.68319412 |
| 70 | PAK3 | 0.66774472 |
| 71 | CAMK1G | 0.66671814 |
| 72 | PDPK1 | 0.66477381 |
| 73 | ARAF | 0.65349697 |
| 74 | LMTK2 | 0.63805400 |
| 75 | RAF1 | 0.63499856 |
| 76 | CDC42BPA | 0.60024881 |
| 77 | PTK2B | 0.59424949 |
| 78 | FYN | 0.56934420 |
| 79 | RPS6KA3 | 0.55988830 |
| 80 | MAP3K7 | 0.55533228 |
| 81 | PRKCZ | 0.53084348 |
| 82 | CAMK1D | 0.50196626 |
| 83 | CAMK2G | 0.49185925 |
| 84 | MAPK12 | 0.48518020 |
| 85 | ERBB3 | 0.46927415 |
| 86 | BMPR2 | 0.43820502 |
| 87 | NEK6 | 0.43237846 |
| 88 | NEK1 | 0.41010345 |
| 89 | MAPK10 | 0.40819944 |
| 90 | CSNK1D | 0.40742231 |
| 91 | CAMK2D | 0.40347317 |
| 92 | BRSK1 | 0.39926835 |
| 93 | MAP3K6 | 0.39670939 |
| 94 | ERBB2 | 0.39491968 |
| 95 | RPS6KB1 | 0.38933306 |
| 96 | DMPK | 0.37447154 |
| 97 | PRKCE | 0.36127992 |
| 98 | MAP3K1 | 0.35861693 |
| 99 | CSNK1E | 0.35466526 |
| 100 | PRKG1 | 0.34954593 |
| 101 | TRIB3 | 0.34823619 |
| 102 | ICK | 0.33476860 |
| 103 | DAPK3 | 0.33322565 |
| 104 | MAPK8 | 0.33224550 |
| 105 | BRAF | 0.32369803 |
| 106 | PKN1 | 0.32320797 |
| 107 | GSK3B | 0.32100265 |
| 108 | MAP2K6 | 0.31423996 |
| 109 | PRKCB | 0.31247700 |
| 110 | CCNB1 | 0.31207178 |
| 111 | ROCK2 | 0.30269929 |
| 112 | RPS6KA2 | 0.28240019 |
| 113 | PRKDC | 0.26657732 |
| 114 | PRKCA | 0.25654275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.87988125 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.07488860 |
| 3 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.85219819 |
| 4 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.84113167 |
| 5 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.77755524 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69032311 |
| 7 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.54032237 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.46858845 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.39545642 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36919557 |
| 11 | * Morphine addiction_Homo sapiens_hsa05032 | 2.30784149 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.18873431 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10746977 |
| 14 | Long-term depression_Homo sapiens_hsa04730 | 2.09685106 |
| 15 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.92960454 |
| 16 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.89190242 |
| 17 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.84618402 |
| 18 | * Insulin secretion_Homo sapiens_hsa04911 | 1.83864684 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.83629603 |
| 20 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69023898 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.66210040 |
| 22 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66199925 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.57290376 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.54559693 |
| 25 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52614032 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.50039805 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.44852003 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43310014 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.42699737 |
| 30 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38471061 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33904302 |
| 32 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29418190 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28998831 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23929190 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21960486 |
| 36 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21814055 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.21196525 |
| 38 | * Gap junction_Homo sapiens_hsa04540 | 1.20834807 |
| 39 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19916343 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.10339311 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09449350 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07104335 |
| 43 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06794323 |
| 44 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.95055480 |
| 45 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92024036 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91079763 |
| 47 | * Melanogenesis_Homo sapiens_hsa04916 | 0.90616737 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88765276 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84451169 |
| 50 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.83546432 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83356689 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81150059 |
| 53 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80724889 |
| 54 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80120845 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77478658 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77325741 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75375851 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75226757 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74429117 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73653284 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73362023 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71900275 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.68995548 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68006816 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66142603 |
| 66 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61306089 |
| 67 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61103109 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59589086 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59493703 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59385964 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.56141095 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52896777 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51667559 |
| 74 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51564639 |
| 75 | * Bile secretion_Homo sapiens_hsa04976 | 0.50991317 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50063145 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50009333 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49480156 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48425881 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47728312 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45730936 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45263301 |
| 83 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44948441 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43943764 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43561246 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42107134 |
| 87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40430969 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.40071732 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39871587 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39241701 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37831103 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37211731 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36759627 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33127016 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32825321 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32637768 |
| 97 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32423484 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32112960 |
| 99 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31961297 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31547103 |
| 101 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30955368 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30808533 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30234073 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.28683417 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27248880 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.26593898 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25836744 |
| 108 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24793817 |
| 109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23526801 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19527643 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18763848 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17906476 |

